Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Healthcare Industry News LivsMed completes $94m KOSDAQ IPO, eyes US entry and robotic expansion LivsMed raised $94M in Korea’s largest 2025 IPO to fund global expansion. Find out how it plans to challenge surgical incumbents with its platform strategy. byPallavi MadhirajuJanuary 17, 2026